Introduction
Fondita Healthcare invests in shares of publicly traded companies whose activities promote health and well-being. The fund’s growth is driven by an aging population, increased prosperity (wealth and living standards), technological development, climate and environmental change and the healthcare sector’s low price-elasticity.
Fondita Healthcare is an actively managed fund with approx. 30 holdings. The fund is primarily aimed at long-term investors. The fund avoids investments in loss-making biotechnology companies.
The fund´s investment decisions take the environmental and social impacts of companies and governance into account, as well as risks related to this.
Fund facts
| Fund size | 92,9 |
| Fund unitholders | 265 |
| ISIN (A) | FI4000321088 |
| ISIN (B) | FI4000321096 |
| Legal structure | UCITS |
| Currency | EUR |
| Management fee | 2,00 % p.a. |
| Risk profile | 5/7 |
| SFDR Classification | Article 8 |
Top 5 Holdings
| Siegfried Holding (CH) | 5,5 % |
| Straumann (CH) | 4,7 % |
| Medicover (SE) | 4,1 % |
| Lonza Group (CH) | 3,9 % |
| Novo Nordisk A/S (DK | 3,7 % |
Top 5 Countries
| Switzerland | 25 % |
| USA | 19 % |
| Germany | 16 % |
| Denmark | 13 % |
| Sweden | 11 % |
Return
| 1 month | 6,1 % |
| 3 months | 8,9 % |
| 6 months | 10,6 % |
| YTD | 29,8 % |
| 1 year | 29,8 % |
| 3 years | 101,2 % |
| since launch (14.6.2018) | 79,1 % |
| since launch p.a. | 17,9 % |
Portfolio managers
Sector Division
| Health Care | 99 % |
| Consumer Discretionary | 2 % |
| Cash | 1 % |
Top 10 Holdings
| Siegfried Holding (CH) | 5,5 % |
| Straumann (CH) | 4,7 % |
| Medicover (SE) | 4,1 % |
| Lonza Group (CH) | 3,9 % |
| Novo Nordisk A/S (DK | 3,7 % |
| Astra Zeneca (SE) | 3,5 % |
| Siemens Healthineers (GB) | 3,5 % |
| Eli Lilly (US) | 3,4 % |
| Carl Zeiss (DE) | 3,2 % |
| Smith & Nephew (GB) | 3,0 % |
Country Division
| Switzerland | 25 % |
| USA | 19 % |
| Germany | 16 % |
| Denmark | 13 % |
| Sweden | 11 % |
| Finland | 5 % |
| Great Britain | 3 % |
| Spain | 3 % |
| Netherlands | 3 % |
| Belgium | 1 % |
| Cash | 2 % |
Currency Exposure
| EUR | 27 % |
| CHF | 25 % |
| USD | 19 % |
| SEK | 11 % |
| DKK | 13 % |
| GBP | 3 % |
The past performance of the investment fund does not provide any guarantee of future results. Depending on market conditions, the fund unit value may rise or fall.
Risk Profile
- 1
- 2
- 3
- 4
- 5
- 6
- 7
Less risk
More risk
A high number means that the fund has a higher risk and that the value of the fund can vary greatly. This means that both return and risk potential is greater.
Return
| 1 month | 6,1 % |
| 3 months | 8,9 % |
| 6 months | 10,6 % |
| YTD | 29,8 % |
| 1 year | 29,8 % |
| since launch (14.6.2018) | 79,1 % |
| since launch p.a. | 17,9 % |
Std Dev
| 3 years | 15,29 % |
| since launch (14.6.2018) | 15,85 % |
Sharpe
| 3 years | 1,64 |
| Launch | 1,18 |
Fees
| TER | 2,00 % |
| Subscription fee | 0,00 % |
| Redemption fee | 1,00 % |
Total client relationship allow for changes in tariff rate.
Downloadable Documents
31.12.2021